CD8A and neoplasm: Due to the high expression of inhibitory ligands such as PD-L1 and the low levels of co-stimulatory ligands on the surface of tumor cells, when tumor cells bind to CD8+ T cells, they enhance the inhibitory signal and diminish or even inhibit the killing capacity of T cells, thus helping tumors to evade CTL killing.